Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > BAFF

BAFF

Brief Information

Name:B-cell-activating factor/B lymphocyte stimulator
Target Synonym:Dendritic Cell-Derived TNF-Like Molecule,B-Cell-Activating Factor,CD257,Epididymis Secretory Sperm Binding Protein,Tumor Necrosis Factor-Like Protein ZTNF4,Delta4 BAFF,BAFF,THANK,BLYS,ApoL Related Ligand TALL-1,TNF Superfamily Member 13b,Delta BAFF,TALL-1,Tumor Necrosis Factor Ligand 7A,B-Cell Activating Factor,B Lymphocyte Stimulator,B-Lymphocyte Stimulator,TNF And ApoL-Related Leukocyte Expressed Ligand 1,ZTNF4,Tumor Necrosis Factor (Ligand) Superfamily, Member 20,TNF- And APOL-Related Leukocy
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:8
Lastest Research Phase:Approved

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
BAF-M82Q3 Mouse Biotinylated Mouse BAFF / TNFSF13B / CD257 Protein, Avitag™,His Tag, active trimer (MALS verified)
BAF-M82Q3-sds
BAF-M5263 Mouse Mouse BAFF / TNFSF13B / CD257 Protein, Fc Tag, active trimer (MALS verified)
BAF-M5263-structure
BAF-M5263-sds
BAF-M82F7 Mouse Biotinylated Mouse BAFF / TNFSF13B / CD257 Protein, Avitag™,Fc Tag, active trimer (MALS verified)
BAF-M82F7-structure
BAF-M82F7-sds
BAF-H52D6 Human Human BAFF / TNFSF13B / CD257 Protein, His,Flag Tag (C-LPETG), active trimer (MALS verified)
BAF-H52D6-sds
BAF-M8219 Mouse Biotinylated Mouse BAFF / TNFSF13B / CD257 Protein, Tag Free, ultra sensitivity (primary amine labeling)
BAF-M8219-structure
BAF-M8219-sds
BAF-H52D4 Human Human BAFF / TNFSF13B / CD257 Protein, His,Flag Tag, active trimer (MALS verified)
BAF-H52D4-sds
BAF-H5261 Human Human BAFF / TNFSF13B / CD257 Protein, Fc Tag, active trimer (MALS verified)
BAF-H5261-sds
BAF-M521y Mouse Mouse BAFF / TNFSF13B / CD257 Protein, Tag Free
BAF-M521y-structure
BAF-M521y-sds
BAF-M5257 Mouse Mouse BAFF / TNFSF13B / CD257 Protein, Mouse IgG2a Fc Tag, low endotoxin
BAF-M5257-structure
BAF-M5257-sds
BAF-H82F3 Human Biotinylated Human BAFF / TNFSF13B / CD257 Protein, Avitag™,Fc Tag, active trimer (MALS verified)
BAF-H82F3-structure
BAF-H82F3-sds
BAF-H82Q2 Human Biotinylated Human BAFF / TNFSF13B / CD257 Protein, His,Avitag™, active trimer (MALS verified)
BAF-H82Q2-structure
BAF-H82Q2-sds
ACRO Quality

Part of Bioactivity data

BAF-H52D4-Cell-based assay
BAFF CELL

Human BAFF Protein, His,Flag Tag (Cat. No. BAF-H52D4) stimulates proliferation of mouse spleen cells. The EC50 for this effect is 1.97-2.90 ng/mL (Routinely tested).

Protocol
BAF-H5261-Cell-based assay
BAFF CELL

Human BAFF Protein, Fc Tag (Cat. No. BAF-H5261) stimulates proliferation of mouse spleen cells. The EC50 for this effect is 4.91-9.81 ng/mL (Routinely tested).

Protocol
BAF-H52D4-SPR
BAFF SPR

Human BAFFR Protein, Fc Tag (Cat. No. BAR-H5257) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human BAFF Protein, His,Flag Tag (Cat. No. BAF-H52D4) with an affinity constant of 5.54 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

Protocol
BAF-H5261-SPR
BAFF SPR

Immobilized Human BAFF Protein, Fc Tag (Cat. No. BAF-H5261) on CM5 Chip can bind Human TACI Protein, Fc Tag with an affinity constant of 0.658 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

Protocol

Synonym Name

TNFSF13B,BAFF,BLYS,CD257,DTL,TALL1,THANK,TNFSF20,ZTNF4,TALL-1

Background

B-cell activating factor (BAFF) is also known as tumor necrosis factor ligand superfamily member 13B , TNFSF13B, BAFF, B Lymphocyte Stimulator (BLyS) , cluster of differentiation 257 (CD257), DTL, TNF- and APOL-related leukocyte expressed ligand (TALL-1), THANK, TNFSF20, ZTNF4, and is a  cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for receptors TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR. This cytokine is expressed in B cell lineage cells, and acts as a potent B cell activator. It has been also shown to play an important role in the proliferation and differentiation of B cells. It is expressed as transmembrane protein on various cell types including monocytes, dendritic cells and bone marrow stromal cells. BAFF is the natural ligand of three unusual tumor necrosis factor receptors named BAFF-R, TACI, and BCMA, all of which have differing binding affinities for it. These receptors are expressed mainly on mature B lymphocytes (TACI is also found on a subset of T-cells and BCMA on plasma cells). TACI binds worst since its affinity is higher for a protein similar to BAFF, called a proliferation-inducing ligand (APRIL). BCMA displays an intermediate binding phenotype and will work with either BAFF or APRIL to varying degrees. Signaling through BAFF-R and BCMA stimulates B lymphocytes to undergo proliferation and to counter apoptosis. All these ligands act as heterotrimers (i.e. three of the same molecule) interacting with heterotrimeric receptors, although BAFF has been known to be active as either a hetero- or homotrimer. BAFF acts as a potent B cell activator and has been shown to play an important role in the proliferation and differentiation of B cells. 

Clinical and Translational Updates

Related Molecule

BCMA

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Telitacicept RCT-18; RC-18; RCT18; RC18 Approved RemeGen Co Ltd 泰爱 Mainland China Lupus Erythematosus, Systemic RemeGen Co Ltd 2021-03-09 Myasthenia Gravis; Multiple Sclerosis, Relapsing-Remitting; Glomerulonephritis, IGA; Nephrosis; Immunoglobulin G4-Related Disease; Sjogren's Syndrome; Arthritis, Rheumatoid; Multiple Sclerosis; Lupus Nephritis; Neuromyelitis Optica; Lupus Erythematosus, Systemic Details
Belimumab BmAb; GSK-1550188; HGS-1006 Approved Glaxosmithkline Plc Benlysta, 倍力腾 United States Lupus Erythematosus, Systemic Human Genome Sciences Inc 2011-03-09 Antiphospholipid Syndrome; Leukemia, Lymphocytic, Chronic, B-Cell; Bronchial Diseases; Emphysema; Pulmonary Disease, Chronic Obstructive; Waldenstrom Macroglobulinemia; Hepatitis, Autoimmune; Lymphopenia; Rheumatic Diseases; Sjogren-Larsson Syndrome; Lupus Erythematosus, Systemic; systemic sclerosis-associated interstitial lung disease; Mixed Connective Tissue Disease; Myasthenia Gravis; Glomerulonephritis, Membranous; Lung Diseases, Interstitial; Lupus Nephritis; Graft vs Host Disease; Purpura; Arthritis, Rheumatoid; Scleroderma, Systemic; Myositis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Granulomatosis with Polyangiitis; Rejection of renal transplantation Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Atacicept TACI-Ig Phase 3 Clinical Zymogenetics Inc Glomerulonephritis, IGA; Kidney Diseases; Arthritis, Rheumatoid; Multiple Sclerosis; Optic Neuritis; Lupus Nephritis; Urinary Bladder Diseases; Lupus Erythematosus, Systemic Details
Povetacicept ALPN-303; ALPN 30x Phase 3 Clinical Alpine Immune Sciences Inc Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Purpura, Thrombocytopenic, Idiopathic; Myasthenia Gravis; Glomerulonephritis, IGA; Sjogren's Syndrome; Glomerulonephritis, Membranous; Lupus Nephritis; Lupus Erythematosus, Systemic; Anemia, Hemolytic, Autoimmune; Inflammation; Cytopenia; Glomerulonephritis Details
Rozibafusp alfa MEDI-0700; AMG-570 Phase 2 Clinical Amgen Inc Arthritis, Rheumatoid; Lupus Erythematosus, Systemic Details
Tabalumab LY-2127399 Phase 2 Clinical Eli Lilly And Company Multiple Sclerosis, Relapsing-Remitting; Dermatomyositis; Scleroderma, Systemic; Arthritis, Rheumatoid; Autoimmune Diseases; Multiple Sclerosis; Arthritis, Juvenile; Multiple Myeloma; Connective Tissue Diseases; Lupus Erythematosus, Systemic; Pemphigus; Kidney Failure, Chronic Details
Tibulizumab LY-3090106; LY3090106; ZB-106 Phase 1 Clinical Eli Lilly And Company Sjogren's Syndrome; Arthritis, Rheumatoid; Sjogren-Larsson Syndrome Details
UBP-1213 UBP-1213; UBP 1213sc Phase 1 Clinical Wuhan Huaxin Kangyuan Biomedicine Co Ltd Lupus Erythematosus, Systemic Details
Autologous CAR-T cell therapy expressing the BAFF-ligand LMY-920; LUMT1A22 Phase 1 Clinical Luminary Therapeutics Inc Sjogren's Syndrome; Scleroderma, Systemic; Multiple Myeloma; Lupus Erythematosus, Systemic; Lymphoma, Mantle-Cell Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap